[1] Flegal KM, Carroll MD, Kit BK, Ogden CL. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999–2010. JAMA. 2012;307:491–7.
[2] “Obesity and overweight,” December 2014, http://www.who. int/mediacentre/factsheets/fs311/en/.
[3] “Controlling the global obesity epidemic,” December 2014.
[4] Schuppan D and Schattenberg JM. “Non-alcoholic steatohepatitis: pathogenesis and novel therapeutic approaches,” Journal of Gastroenterology and Hepatology, vol. 28, pp. 68–76, 2013.
[5] Aksungar F B, Eren A, Ure S, Teskin O and Ates G. “Effects of intermittent fasting on serum lipid levels, coagulation status and plasma homocysteine levels,” Annals of Nutrition & Metabolism, vol. 49, no. 2, pp. 77–82, 2005.
[6] Norouzy, A., Salehi, M., Philippou E.et al., “Effect of fasting in Ramadan on body composition and nutritional intake: a prospective study,” Journal of Human Nutrition and Dietetics, vol. 26, Supplement 1, pp. 97–104, 2013.
[7] Temizhan, A., Tandogan,I., Dönderici, O. and Demirbas, B. “The effects of Ramadan fasting on blood lipid levels,” The American Journal of Medicine, vol. 109, no. 4, pp. 341-342, 2000.
[8] Hatori, M., Vollmers, C., Zarrinpar A.et al., “Time-restricted feeding without reducing caloric intake prevents metabolic diseases in mice fed a high-fat diet,” Cell Metabolism,
vol. 15, no. 6, pp. 848–860, 2012.
[9] A. I. Al-Shafei,“Ramadan fasting ameliorates oxidative stress and improves glycemic control and lipid profile in diabeticpatients,”European Journal of Nutrition, vol. 53, no. 7,pp. 1475–1481, 2014.
[10] A. I. Al-Shafei,“Ramadan fasting ameliorates arterialpulse pressure and lipid profile, and alleviates oxidative stress in hypertensive patients,”Blood Pressure, vol. 23,no. 3, pp. 160–167, 2014.
[11] M. Hatori, C. Vollmers, A. Zarrinpar et al.,“Time-restricted feeding without reducing caloric intake prevents metabolic diseases in mice fed a high-fat diet,”Cell Metabolism,vol. 15, no. 6, pp. 848–860,2012.
[12] Wing RR, Lang W, Wadden TA, Safford M, Knowler WC, BertoniAG, et al. Benefits of modest weight loss in improving cardiovascular risk factors in overweight and obese individuals with type 2 diabetes. Diab Care. 2011;34:1481–6.
[13] National Heart Lung and Blood Institute (NHLBI). Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: the evidence report: National Institutes of Health. Obes Res. 1998;6Suppl 2:51S–209S. Erratum, Obes Res 1998;6:464.
[14] Bechtold DA, Loudon AS. Hypothalamic clocks and rhythms infeeding behaviour. Trends Neurosci. 2013;36:74–82.
[15] Drapeau V, Gallant AR. Homeostatic and circadian control of food intake: clinical strategies to prevent overconsumption. CurrObesRep. 2013;2:93–103.
[16] Longo VD, Mattson MP. Fasting: Molecular mechanisms and clinical applications. Cell Metab. 2014;19(2):181-92.
[17] Longo VD, Panda S. Fasting, Circadian Rhythms, and Time-Restricted Feeding in Healthy Lifespan. Cell Metab. 2016;23(6):1048-59.
[18] Chaix A, et al. Time-restricted feeding is a preventative and therapeutic intervention
against diverse nutritional challenges. Cell Metab. 2014;20(6):991-1005.
[19] Gill S, Panda S. A Smartphone App Reveals Erratic Diurnal Eating Patterns in Humans that Can Be Modulated for Health Benefits. Cell Metab. 2015;22(5):789-98.
[20] Mosley, M.; Spencer, M. A Dieta dos 2 Dias—The Fast Diet; Sextante: Belo Horizonte, Brazil, 2013.
[21] Musunuru K. Atherogenic dyslipidemia: cardiovascular risk and dietary intervention. Lipids. 2010;45:907–14.
[22] Kris-Etherton PM, Binkoski AE, Zhao G, Coval SM, Clemmer KF, Hecker HD, Jacques H, Etherton TD. Dietary fat: assessing the evidence in support of a moderate-fat diet; the benchmark based on lipoprotein metabolism. Proc Nutr Soc. 2002;61:287–98.
[23] Panel ED, Grundy SM. An international atherosclerosis society position paper: global recommendations for the management of dyslipidemia. J Clin Lipidol. 2013;7:561–5.
[24] Varady KA, Jones PJ. Combination diet and exercise interventions for the treatment of dyslipidemia: an effective preliminary strategy to lower cholesterol levels? J Nutr. 2005;135:1829–35.
[25] Executive Summary of the Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation And Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) JAMA. 2001; 285: 2486–97.
[26] T. Vos, S.S. Lim, C. Abbafati, et al.Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet, 396 (2020), pp. 1204-1222
[27] Klop B, Elte JWF, Cabezas MC. Dyslipidemia in obesity: mechanisms and potential targets. Nutrients. 2013;5(4):1218–40.
[28] Niroumand S, Khajedaluee M, Khadem-Rezaiyan M, Abrishami M, Juya M, Khodaee G, et al. Atherogenic index of plasma (AIP): a marker of cardiovascular disease. Med J Islam Repub Iran. 2015;29:240.
[29] Kasai T, Miyauchi K, Yanagisawa N, et al. Mortality risk of triglyc-eride levels in patients with coronary artery disease.Heart.2013;99(1):22-29.
[30] Sarwar N, Danesh J, Eiriksdottir G, et al. Triglycerides and therisk of coronary heart disease: 10,158 incident cases among262,525 participants in 29 Western prospective studies.Circula-tion. 2007;115(4):450-458.
[31] Varady KA, Bhutani S, Klempel MC, Lamarche B: Improvements in LDL particle size and distribution by short-term alternate day modified fasting in obese adults. Br J Nutr 2011, 105:580–583.
[32] Klempel MC, Kroeger CM, Varady KA: Alternate day fasting increases LDL particle size independently of dietary fat content in obese humans. Eur J ClinNutr 2013.
[33] Bhutani S, Klempel MC, Kroeger CM, Trepanowski JF, Varady KA. Alternate day fasting and endurance exercise combine to reduce body weight and favorably alter plasma lipids in obese humans. Obesity. 2013;21:1370–9.
[34] Klempel MC, Kroeger CM, Bhutani S, Trepanowski JF, Varady KA. Intermittent fasting combined with calorie restriction is effective for weight loss and cardio-protection in obese women. Nutr J. 2012;11:98.
[35] Klempel MC, Kroeger CM, Varady KA. Alternate day fasting increases LDL particle size independently of dietary fat content in obese humans. Eur J ClinNutr. 2013;67:783 5.
[36] Mechanick JI, Zhao S, Garvey WT. Leptin, An Adipokine With Central Importance in the Global Obesity Problem. Glob Heart. 2017 Dec 13. [Epub ahead of print]
[37] Crujeiras AB, Carreira MC, Cabia B, Andrade S, Amil M, Casanueva FF. Leptin resistance in obesity: an epigenetic landscape. Life Sci 2015; 140: 57–63.
[38] Scarpace PJ, Zhang Y. Elevated leptin: Consequence or cause of obesity? Front Biosci. 2007; 12:3531-44.
[39] Bell BB, Rahmouni K. Leptin as a Mediator of Obesity-Induced Hypertension. Curr Obes Rep 2016; 5: 397–404.
[40] Stepien M, Stepien A, Wlazel RN, Paradowski M, Rizzo M, Banach M, et al. Predictors of insulin resistance in patients with obesity: a pilot study. Angiology 2014; 65: 22–30.
[41] Pérez-Pérez A, Vilariño-García T, Fernández-Riejos P, Martín-González J, Segura-Egea JJ, Sánchez-Margalet V. Role of leptin as a link between metabolism and the immune system. Cytokine Growth Factor Rev 2017; 35: 71–84.
[42] Beltowski J. Leptin and atherosclerosis. Atherosclerosis 2006; 189: 47–60.
[43] Kamyabi Z, Gholamalizade T: A comparative study of serum and follicular fluid leptin concentrations among explained infertile, unexplained infertile and fertile women. Int J Fertil Steril. 2015, 9:150-156.
[44]. Ruxton CH, Kirk TR. Breakfast: a review of associations with measures of dietary intake, physiology and biochemistry.Br J Nutr 1997; 78: 199-213.
[45] Affenito SG. Breakfast: a missed opportunity. J Am Diet Assoc 2007; 107: 565-9.
[46] Farshchi HR, Taylor MA, Macdonald IA. Deleterious effects of omitting breakfast on insulin sensitivity and fasting lipid profiles in healthy lean women. Am J Clin Nutr 2005; 81: 388-96.
[47] Sifferlin, A., 2013. When to eat breakfast, lunch and dinner. Time, (July 23rd) ⟨http://time.com/4408772/besttimesbreakfastlunchdinner/⟩.